CHINA PHARMA HOLDINGS, INC. (CPHI) › Total AssetsCHINA PHARMA HOLDINGS, INC. (CPHI) — Total AssetsAnnual figures by period end, from SEC filings.2010-12-31: $131.75M2011-12-31: $156.39M2012-12-31: $163.24M2013-12-31: $157.61M2014-12-31: $121.08M2015-12-31: $96.51M2016-12-31: $78.52M2017-12-31: $59.95M2018-12-31: $45.38M2019-12-31: $22.24M2020-12-31: $21.12M2021-12-31: $22.65M2022-12-31: $17.78M2023-12-31: $16.47M2024-12-31: $14.89M2025-12-31: $31.00M$31.00M2010-12-31Total Assets (USD)2025-12-31Period endedTotal AssetsChange YoYSource filing2025-12-31$31.00M+108.2%2026-04-01Balance as of period end2024-12-31$14.89M-9.6%2026-04-01Balance as of period end2023-12-31$16.47M-7.4%2025-03-31Balance as of period end2022-12-31$17.78M-21.5%2024-04-01Balance as of period end2021-12-31$22.65M+7.3%2023-03-30Balance as of period end2020-12-31$21.12M-5.0%2022-03-30Balance as of period end2019-12-31$22.24M-51.0%2021-03-26Balance as of period end2018-12-31$45.38M-24.3%2020-03-30Balance as of period end2017-12-31$59.95M-23.6%2019-03-28Balance as of period end2016-12-31$78.52M-18.6%2018-04-02Balance as of period end2015-12-31$96.51M-20.3%2017-03-31Balance as of period end2014-12-31$121.08M-23.2%2016-03-30Balance as of period end2013-12-31$157.61M-3.4%2015-12-28Balance as of period end2012-12-31$163.24M+4.4%2014-03-20Balance as of period end2011-12-31$156.39M+18.7%2013-03-14Balance as of period end2010-12-31$131.75M—2012-03-14Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)